Cumberland Pharmaceuticals Inc (CPIX): Depreciation & Amortization
$4.15M
Year ended 2025-12-31
-8.0%
3-year compound annual growth
-2.7%
5-year compound annual growth
+6.3%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.15M | -15.4% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $4.90M | -0.7% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $4.94M | -7.4% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $5.33M | +15.7% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $4.61M | -3.0% | 2023-03-13, From 2021-01-01 |
| 2020-12-31 | $4.75M | +7.8% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $4.40M | +47.7% | 2022-03-11, From 2019-01-01 |
| 2018-12-31 | $2.98M | +12.7% | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $2.65M | +10.5% | 2020-03-20, From 2017-01-01 |
| 2016-12-31 | $2.40M | +6.7% | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $2.25M | +12.9% | 2018-03-09, From 2015-01-01 |
| 2014-12-31 | $1.99M | +52.8% | 2017-03-13, From 2014-01-01 |
| 2013-12-31 | $1.30M | +44.4% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $901.6K | -13.3% | 2015-03-09, From 2012-01-01 |
| 2011-12-31 | $1.04M | +6.3% | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $978.4K | +19.8% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $816.5K | n/a | 2012-03-07, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $4.15M | -15.4% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $548.0K | -23.7% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $1.54M | -6.3% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $1.60M | +14.3% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $1.28M | +55.0% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $138.0K | -67.2% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $24.0K | -97.1% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $621.0K | +16.3% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $4.32M | +14.2% |
Compare CPIX, AQST, XLO, SEPN side by side · Screen every company in Pharmaceutical Preparations ↗